Brits to vaccinate schoolgirls against HPV

The British government just made Merck's day--or was it GlaxoSmithKline's? U.K. schoolgirls will be vaccinated against the human papilloma virus that causes cervical cancer. And it's not just the 12- and 13-year-olds initially recommended to get the shot, but young women up to age 18, too.

The government stopped short of recommending which version of the vaccine to use. Both Gardasil, made by Merck and Sanofi Pasteur, and Cervarix, made by Glaxo, are approved for use in the U.K. Glaxo's version launched only recently, while Merck has had more time to get a toehold in the market.

- read the story at the BBC's website

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.